Supplement

GenoPalate Selected as a Spotlight Innovator at the Inaugural Innovation Experience Showcase at Expo East 2023

Retrieved on: 
Tuesday, September 19, 2023
Science, The Vitamin Shoppe, DNA profiling, Health, Supplement, Genetics, Genome, Agriculture, Dietary supplement

MILWAUKEE, Sept. 19, 2023 /PRNewswire/ -- GenoPalate , the leading U.S. genomic nutrition platform, is proud to announce its selection as a highlighted innovative business for the first-ever Innovation Experience showcase.

Key Points: 
  • MILWAUKEE, Sept. 19, 2023 /PRNewswire/ -- GenoPalate , the leading U.S. genomic nutrition platform, is proud to announce its selection as a highlighted innovative business for the first-ever Innovation Experience showcase.
  • Since its inception in 2016, GenoPalate has been leading the science based on personalized nutrition based on genetics.
  • "Being recognized at the Innovation Experience showcase is a testament to the transformative work we've been championing over the years," expressed Sherry Zhang, Founder of GenoPalate.
  • Highlighting GenoPalate's impactful presence at the expo, Sherry Zhang has been selected to speak on the Supplement & Retail Leadership Panel.

Polarean Partners with VIDA to Streamline Adoption of Advanced MRI of the Lungs

Retrieved on: 
Friday, September 8, 2023
Xenon, Risk, Partnership, Radiation, Inhalation, Transience, AIM, Doctor of Philosophy, Supplement, Clinical trial, Hypoesthesia, Research, Biomarker, VIDA, MRI, Magnetic resonance imaging, Dizziness, Severe cutaneous adverse reactions, Oxygen saturation (medicine), Patient, Acquisition, Physician, Algorithm, Euphoria, Ageing, Hypoxemia, Heart rate, Headache, Adolescence, Medical imaging, Adult

The companies are partnering to develop solutions that further enable the Polarean xenon 129 MRI platform to accelerate clinical and research use.

Key Points: 
  • The companies are partnering to develop solutions that further enable the Polarean xenon 129 MRI platform to accelerate clinical and research use.
  • “Furthermore, this partnership perfectly aligns with our objective of extending the reach of XENOVIEW™ MRI, to provide tools to physicians that treat patients suffering from chronic lung disease.”
    “VIDA and Polarean are natural partners.
  • Since the technology is based on MRI, it does not expose patients to any ionizing radiation and its associated risks.
  • The dose of XENOVIEW, created through the Polarean HPX hyperpolarization system, is administered in a single 10-15 second breath-hold MRI procedure.

Liberty Bankers Insurance Group Launches Hospital Indemnity Plus

Retrieved on: 
Wednesday, September 13, 2023
Life, Supplement, Hospital, Health, Family, Life insurance, Health insurance

DALLAS, Sept. 13, 2023 /PRNewswire/ -- Liberty Bankers Insurance Group (LBIG), a nationally recognized provider of life, health, and wealth products, today announces the launch of Hospital Indemnity Plus. This supplemental health product is available through the company's independent agent distribution channel in 23 states, with additional states in the near future.

Key Points: 
  • New Supplemental Product Offers Seven Standard Benefits, Plus Nine Optional Riders
    DALLAS, Sept. 13, 2023 /PRNewswire/ -- Liberty Bankers Insurance Group (LBIG), a nationally recognized provider of life, health, and wealth products, today announces the launch of Hospital Indemnity Plus.
  • The hospital indemnity insurance product is offered through Liberty Bankers Life Insurance Company, a member of Liberty Bankers Insurance Group.
  • "Prolonged hospital stays can add unnecessary stress and financial burden to families," said Dave Peters, senior vice president, supplemental health division at Liberty Bankers Insurance Group.
  • "At LBIG, we help people manage life's risks," said Brian Clark, executive vice president and chief marketing officer at Liberty Bankers Insurance Group.

Statement: Older Adult Poverty Continues Upward Trend, Reaching an Unacceptable 14%

Retrieved on: 
Wednesday, September 13, 2023
Poverty, Housing, Senate, Supplemental Nutrition Assistance Program, Supplement, Forest Law Enforcement and Governance Program, Woman, SNAP, National Council on Aging, Census, United States Census Bureau, Social Security, National Council, NCOA, Social, House, Birth control, Viticulture, Health insurance

ARLINGTON, Va., Sept. 12, 2023 /PRNewswire/ -- The following is a statement from Ramsey Alwin, President and CEO of the National Council on Aging (NCOA), on the latest U.S. Census Bureau data on poverty, income, and health insurance in 2022.

Key Points: 
  • Ramsey Alwin
    "For three years in a row, more Americans ages 65 and older are living in poverty—robbed of their ability to age with dignity.
  • The latest Census numbers show that under the Supplemental Poverty Measure (SPM), the older adult poverty rate has jumped from 9.5% in 2020 to 10.7% in 2021 to 14.1% in 2022.
  • Combined, the Supplemental Nutrition Assistance Program (SNAP), housing subsidies, and the Supplemental Security Income lifted 1.6 million older adults out of poverty.
  • It's time to stop this upward trend in poverty in its tracks—for Americans of all ages.

Letter From Mark Stewart, Stellantis North America COO, to Employees Regarding the Company's First Economic Proposal to the UAW

Retrieved on: 
Friday, September 8, 2023
UAW, Multimedia, Supplement

Today, we took an important next step in this process by presenting the UAW with our first economic proposal.

Key Points: 
  • Today, we took an important next step in this process by presenting the UAW with our first economic proposal.
  • From the start of these negotiations, we have said we're committed to fairly rewarding you for your hard work and contributions to the success of the company.
  • We wanted to share the details with you because we feel it is important to be transparent about what is currently on the table.
  • It also protects the company's future ability to continue to compete globally in an industry that is rapidly transitioning to electric vehicles.

GNC Partners with SPINS to Enhance Research and Trends Capabilities

Retrieved on: 
Thursday, September 7, 2023
Customer, Customer insight, EVP, Mineral, Partnership, Health, VMS, Vitamin, Supplement, GNC

PITTSBURGH, Sept. 7, 2023 /PRNewswire/ -- To stay informed about pertinent trends, consumer habits, and shoppers' purchasing behaviors, GNC collaborates with some of the industry's best to amplify its expert internal research capabilities. That's why it recently selected SPINS as its new research partner. With a partnership designed to elevate the company's consumer-first mindset and leverage SPINS' expertise in the natural products industry for product development and product design, this collaboration is SPINS' largest VMS partnership to date, and will arm GNC with expansive data in the Vitamin, Mineral and Supplement (VMS) segments. 

Key Points: 
  • PITTSBURGH, Sept. 7, 2023 /PRNewswire/ -- To stay informed about pertinent trends, consumer habits, and shoppers' purchasing behaviors, GNC collaborates with some of the industry's best to amplify its expert internal research capabilities.
  • "GNC and SPINS share a deep commitment to deeply understanding and transforming the future of health and wellness," said Michelle Walkley, Director, Customer Insights, GNC.
  • "Having insight into the SPINS platform is going to enhance our current data-driven approach to understanding market trends and evolving customer needs.
  • Through SPINS proprietary attribution and product intelligence platform, GNC will also be able to accelerate its innovation initiatives.

Kori Krill Oil Omega-3 Is the #1 Brain and Mood Support Supplement

Retrieved on: 
Tuesday, August 29, 2023
Marketing, GMO, Ageing, Cancer, Nutrient, Brain, Inflammation, Softgel, Immune system, Joint, Growth, Health, Skin, Dietary supplement, Supplement

NEW YORK, Aug. 29, 2023 /PRNewswire/ -- Smart Drugs and Supplements, a digital publication, has honored Kori Krill Oil as the No. 1 Supplement for Brain and Mood Support. Krill oil, derived from small shrimp-like creatures in the ocean around Antarctica, has been gaining popularity in recent years as an alternative to fish oil. Both sources are rich in omega-3 acids, which have a variety of health benefits. [See Full Press Release.]

Key Points: 
  • NEW YORK, Aug. 29, 2023 /PRNewswire/ -- Smart Drugs and Supplements, a digital publication, has honored Kori Krill Oil as the No.
  • 1 Supplement for Brain and Mood Support.
  • Krill oil, derived from small shrimp-like creatures in the ocean around Antarctica, has been gaining popularity in recent years as an alternative to fish oil.
  • Appealing to a younger set of consumers is an important part of the marketing strategy behind the growth of krill oil products, and Kori Krill Oil gets high marks from these consumers for its organic and natural products.

Intelligent Bio Solutions Inc. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Operational Highlights

Retrieved on: 
Thursday, August 24, 2023
Haulage, University, Diabetes, Quarter, Eastern Airways, Classification, Marketing, Cortisol, Government, U.S. FDA, TTR, Correlation, Blood, The Company, Acquisition, Patent, Collection, Growth, FDA, Intelligence, Supplement, Saliva, Medical device, Pharmaceutical industry, Cryptocurrency, Airline, Glucose

NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("Intelligent Bio Solutions," "INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results for its fiscal fourth quarter and full-year ended June 30, 2023, and provided a business update.

Key Points: 
  • “In the 2023 fiscal year, we maintained rapid expansion of our customer footprint, successfully entering the Australian market with accelerated uptake,” said Harry Simeonidis, President and Chief Executive Officer of Intelligent Bio Solutions.
  • In addition, we further strengthened the protection of our unique and proprietary drug screening technology with the award of our 13th patent.
  • The results showed a record 4x improvement in TTR, enabling the biosensor to return test results in under one minute.
  • Fourth Quarter and Full Year Ended June 30, 2023, Financial Results
    All amounts are expressed in U.S. dollars unless indicated otherwise.

Cybin Announces Renewed At-The-Market Equity Program of up to US$35 Million

Retrieved on: 
Thursday, August 24, 2023
Biotechnology, Mental Health, Alternative Medicine, Health, Pharmaceutical, Standby Equity Distribution Agreement, Treasury, Purchasing, Inc., NEO Exchange, Asset purchase agreement, University Avenue, EDGAR, Sale, Suite, Equity capital markets, Sales management, National instrument, ATTN:, Intermediary, Form, NYSE American, Supplement, NYSE, LPC, News, NEO, Security (finance), Property management, Share (finance)

Cybin intends to use the net proceeds from sales of Shares under the ATM Program, if any, for growth opportunities and working capital initiatives.

Key Points: 
  • Cybin intends to use the net proceeds from sales of Shares under the ATM Program, if any, for growth opportunities and working capital initiatives.
  • The ATM Program will be effective until the earlier of the issuance and sale of all of the Shares issuable pursuant to the ATM Program and September 17, 2025 unless earlier terminated in accordance with the terms of the Distribution Agreement.
  • The volume and timing of distributions under the ATM Program, if any, will be determined in Cybin’s sole discretion and in accordance with the Distribution Agreement.
  • The Supplement and accompanying Base Prospectus contain important detailed information about the ATM Program.